Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 May;12(5):561-576.
doi: 10.1002/mdc3.70010. Epub 2025 Feb 20.

Neuroimaging Techniques in Huntington's Disease: A Critical Review

Affiliations
Review

Neuroimaging Techniques in Huntington's Disease: A Critical Review

Mena Farag et al. Mov Disord Clin Pract. 2025 May.

Abstract

Background: Huntington's disease (HD) is a hereditary neurodegenerative disorder characterized by cognitive, neuropsychiatric and motor symptoms caused by a CAG trinucleotide repeat expansion in the huntingtin gene. Imaging techniques are crucial for understanding HD pathophysiology and monitoring disease progression.

Objectives: This review is targeted at general neurologists and movement disorders specialists with an interest in HD and aims to bring complex imaging, including new experimental techniques, closer to the practicing clinician.

Methods: We provide a summary of findings from conventional structural, diffusion and functional imaging in HD studies, together with an update on emerging novel techniques, including multiparametric mapping, multi-shell diffusion techniques, ultra-high field 7-Tesla MRI, positron emission tomography and magnetoencephalography.

Results: Conventional imaging techniques have deepened our understanding of neuropathological progression in HD, from striatal atrophy to widespread cortical and white matter changes. The integration of novel imaging techniques reviewed has further improved our ability to interrogate, quantify and visualize disease-specific alterations with high precision.

Conclusions: Novel imaging techniques have promising roles to further our understanding of HD pathology and as imaging markers for clinical trials, disease staging and therapeutic monitoring. Additionally, the synergistic potential of combining imaging modalities with molecular and genetic data, along with wet biomarkers and clinical data, will help provide a complete and comprehensive view of HD pathology and progression.

Keywords: 7 T MRI; Huntington's disease; MEG; PET; machine learning.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Rodrigues FB, Abreu D, Damásio J, et al. Survival, mortality, causes and places of death in a European Huntington's disease prospective cohort. Mov Disord Clin Pract 2017;4(5):737–742. 10.1002/MDC3.12502. - DOI - PMC - PubMed
    1. Sathasivam K, Hobbs C, Turmaine M, et al. Formation of polyglutamine inclusions in non‐CNS tissue. Hum Mol Genet 1999;8:813–822. 10.1093/HMG/8.5.813. - DOI - PubMed
    1. Bates GP, Dorsey R, Gusella JF, et al. Huntington disease. Nat Rev Dis Primers 2015;1:1–21. doi:10.1038/nrdp.2015.5. - DOI - PubMed
    1. Lee JM, Wheeler VC, Chao MJ, et al. Identification of genetic factors that modify clinical onset of Huntington's disease. Cell 2015;162:516–526. 10.1016/J.CELL.2015.07.003. - DOI - PMC - PubMed
    1. Kennedy L, Evans E, Chen CM, et al. Dramatic tissue‐specific mutation length increases are an early molecular event in Huntington disease pathogenesis. Hum Mol Genet 2003;12:3359–3367. 10.1093/HMG/DDG352. - DOI - PubMed

LinkOut - more resources